Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids

References

• Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 2006;13:191–205.
   PubMed Web of Science ®Google Scholar
• Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984;4:79–83.
   PubMedGoogle Scholar
• Rye KA, Barter PJ. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004;24:421–428.
   PubMed Web of Science ®Google Scholar
• Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 2001;1531:4–46.
   PubMed Web of Science ®Google Scholar
• Duong PT, Weibel GL, Lund-Katz S, Rothblat GH, Phillips MC. Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. J Lipid Res 2008;49:1006–1014.
   PubMed Web of Science ®Google Scholar
• Borhani DW, Rogers DP, Engler JA, Brouillette CG. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci U S A 1997;94:12291–12296.
   PubMed Web of Science ®Google Scholar
• Silva RA, Hilliard GM, Fang J, Macha S, Davidson WS. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry 2005;44:2759–2769.
   Google Scholar
• Mei X, Atkinson D. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J Biol Chem 2011;286:38570–38582.
   PubMed Web of Science ®Google Scholar
• Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, et al. The new apolipoprotein A-I variant leu(174)−> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol 1999;155:695–702.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Schönland S, Yumlu S, Hegenbart U, von Hutten H, Gioeva Z, Lohse P, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn 2009;11:257–262.
   PubMed Web of Science ®Google Scholar
• Di Gaetano S, Guglielmi F, Arciello A, Mangione P, Monti M, Pagnozzi D, Raimondi S, et al. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential. Biochem Biophys Res Commun 2006;351:223–228.
   Google Scholar
• Monti DM, Guglielmi F, Monti M, Cozzolino F, Torrassa S, Relini A, Pucci P, et al. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation. Eur Biophys J 2010;39:1289–1299.
   Google Scholar
• Arciello A, De Marco N, Del Giudice R, Guglielmi F, Pucci P, Relini A, Monti DM, Piccoli R. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. J Cell Mol Med 2011;15:2652–2663.
   Google Scholar
• Raimondi S, Guglielmi F, Giorgetti S, Di Gaetano S, Arciello A, Monti DM, Relini A, et al. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I. J Mol Biol 2011;407:465–476.
   Google Scholar
• Schmidt HH, Haas RE, Remaley A, Genschel J, Strassburg CP, Büttner C, Manns MP. In vivo kinetics as a sensitive method for testing physiologically intact human recombinant apolipoprotein A-I: comparison of three different expression systems. Clin Chim Acta 1997;268:41–60.
   Google Scholar
• Mallory JB, Kushner PJ, Protter AA, Cofer CL, Appleby VL, Lau K, Schilling JW, Vigne JL. Expression and characterization of human apolipoprotein A-I in Chinese hamster ovary cells. J Biol Chem 1987;262:4241–4247.
   Google Scholar
• Ryan RO, Forte TM, Oda MN. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003;27:98–103.
   PubMed Web of Science ®Google Scholar
• Lagerstedt JO, Cavigiolio G, Roberts LM, Hong HS, Jin LW, Fitzgerald PG, Oda MN, Voss JC. Mapping the structural transition in an amyloidogenic apolipoprotein A-I. Biochemistry 2007;46:9693–9699.
   Google Scholar
• Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene 2004;327:153–160.
   Google Scholar
• Marchesi M, Parolini C, Valetti C, Mangione P, Obici L, Giorgetti S, Raimondi S, et al. The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease. Biochim Biophys Acta 2011;1812:87–93.
   Google Scholar
• Pérez-Jiménez F, Castro P, López-Miranda J, Paz-Rojas E, Blanco A, López-Segura F, Velasco F, et al. Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis 1999;145:351–358.
   PubMed Web of Science ®Google Scholar
• Nordøy A, Goodnight SH. Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 1990;10:149–163.
   PubMedGoogle Scholar
• Yao Y, Eshun JK, Lu S, Berschneider HM, Black DD. Regulation of triacylglycerol and phospholipid trafficking by fatty acids in newborn swine enterocytes. Am J Physiol Gastrointest Liver Physiol 2002;282:G817–G824.
   Google Scholar
• Wang H, Berschneider HM, Du J, Black DD. Apolipoprotein secretion and lipid synthesis: regulation by fatty acids in newborn swine intestinal epithelial cells. Am J Physiol 1997;272:G935–G942.
   Google Scholar